1. Home
  2. MBBC vs EDSA Comparison

MBBC vs EDSA Comparison

Compare MBBC & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marathon Bancorp Inc.

MBBC

Marathon Bancorp Inc.

N/A

Current Price

$15.23

Market Cap

44.1M

Sector

Finance

ML Signal

N/A

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

N/A

Current Price

$4.66

Market Cap

51.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBBC
EDSA
Founded
1902
2015
Country
United States
Canada
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.1M
51.5M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
MBBC
EDSA
Price
$15.23
$4.66
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
2.0K
75.8K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
122.22
N/A
EPS
0.53
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$29.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.25
$0.72
52 Week High
$15.79
$20.32

Technical Indicators

Market Signals
Indicator
MBBC
EDSA
Relative Strength Index (RSI) 57.44 44.04
Support Level $14.63 $4.80
Resistance Level $15.77 $6.62
Average True Range (ATR) 0.12 0.61
MACD 0.03 0.01
Stochastic Oscillator 93.94 30.98

Price Performance

Historical Comparison
MBBC
EDSA

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: